G Medical Innovations IPO Presentation Deck

Company Overview G Medical is a Next-Generation Tele-Health and At-Home Testing Company We develop and market clinical and consumer medical-grade remote monitoring systems focused on chronic diseases as well as develop and market at-home testing kits which are delivered to & processed by our CLIA certified lab. • We utilize sophisticated Deep Neural Networks based Artificial Intelligence (AI)-backed ECG software which is used as a powerful secondary analysis tool. We have developed At-Home Testing Kits to collect samples of blood, saliva, stool, urine, etc. to be used to detect a multitude of common and less common disorders. We expect to commence sales of the at-home testing kits during Q3 2023. We believe that we are at the forefront of the digital health and at-home testing revolution meant to empower consumers, patients and health care providers to better monitor, manage and improve clinical health outcomes. We focus on chronic diseases such as cardiovascular disease, pulmonary disease, diabetes and obesity. We have enjoyed $21 million in revenue from sales of our devices & monitoring services in the last 4 and a half years. • 7 granted patents covering key aspects of our devices. Digital health devices and monitoring Reduce the Expense in dollars and time in healthcare. Digital health market projected at $316.8 B by 2027

View entire presentation